Skip to main content

NeOnc secures UAE IND clearance for brain tumour drug NEO212 Context Therapeutics: CTIM-76 hits 29% ORR in ovarian cancer Adaptive Biotechnologies plans to spin out Immune Medicine unit Applied Biologics' XWRAP hits wound closure endpoint in CAMPX trial Aptose reports 86% response rate in AML triplet therapy trial at EHA Cardiawave begins routine EU rollout of Valvosoft aortic stenosis device Cuprina wins FDA 510(k) clearance for MEDIFLY Lucilia cuprina maggots Pharvaris deucrictibant Phase 3 HAE data presented at EAACI 2026 Legend Biotech reports 100% ORR for in vivo CAR-T LB2501 in B-NHL XBiotech launches Phase II axial spondyloarthritis trial of vilamakitug VERAXA Biotech lists on Nasdaq via SPAC merger, raises $77.5m Enterome EO2463 hits 74% ORR in iNHL combo cohort at EHA 2026 Nano Dimension signs term sheet to merge with Infinite Epigenetics Eliaz Therapeutics opens Reg CF round to fund sepsis apheresis device Intrommune reports exploratory peanut tolerance data for OMIT NeOnc secures UAE IND clearance for brain tumour drug NEO212 Context Therapeutics: CTIM-76 hits 29% ORR in ovarian cancer Adaptive Biotechnologies plans to spin out Immune Medicine unit Applied Biologics' XWRAP hits wound closure endpoint in CAMPX trial Aptose reports 86% response rate in AML triplet therapy trial at EHA Cardiawave begins routine EU rollout of Valvosoft aortic stenosis device Cuprina wins FDA 510(k) clearance for MEDIFLY Lucilia cuprina maggots Pharvaris deucrictibant Phase 3 HAE data presented at EAACI 2026 Legend Biotech reports 100% ORR for in vivo CAR-T LB2501 in B-NHL XBiotech launches Phase II axial spondyloarthritis trial of vilamakitug VERAXA Biotech lists on Nasdaq via SPAC merger, raises $77.5m Enterome EO2463 hits 74% ORR in iNHL combo cohort at EHA 2026 Nano Dimension signs term sheet to merge with Infinite Epigenetics Eliaz Therapeutics opens Reg CF round to fund sepsis apheresis device Intrommune reports exploratory peanut tolerance data for OMIT

Search

Sign in Create account

Subscribe

Main navigation

News
Sectors
Content
- Analysis
- Interview
- Opinion
- Podcast
- Video
- Webinar
Events
Newsletter
About
Contact

Breadcrumb

Home
Webinar

Webinar

Subscribe to Webinar

Subscribe to The Biotech Times

Email

The subscriber's email address.

Manage your newsletter subscriptions

Biotech Times — Daily Briefing

Biotech Times — Event Alerts

Biotech Times — Monthly Report

Biotech Times — Weekly Sector Digest

Select the newsletter(s) to which you want to subscribe.

Get the biotech news that matters — pick the briefings that suit you.

Sectors you’re interested in

Pick as many as you like — your digest will lead with stories from these sectors. Leave blank if you want everything.

Manage existing

Legal

Privacy Policy
Cookie Policy
Terms of Use
Acceptable Use Policy (Community Guidelines)
Copyright & Takedown Policy
Accessibility Statement

Editorial

AI Use Policy
Editorial Standards & Corrections Policy
Why we ask for your business email
Sponsored Content & Advertising Disclosure

© 2026 Disrupts Media Limited · Company No. 09447878

Registered office: 41 Luke Street, London EC2A 4DP, United Kingdom

hello@disruptsmedia.com · privacy@disruptsmedia.com